The topical testosterone roll-on solution Axiron will no longer be available in Australia, after a licensing deal between its manufacturer and sole distributor was axed. In a letter to doctors, distributor Eli Lilly advises pharmacies will no longer be able to order the testosterone replacement therapy after December 4, when its licensing agreement with Melbourne-based pharmaceutical ...
Roll-on testosterone product exits market
By Tessa Hoffman
14 Nov 2017